• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

U.S. Market for OTC Diet Aids, The

$3,000.00 – $6,000.00

Clear
SKU: KLI927929 Category: Pharmaceuticals Market Research Pages: 234
  • Description
  • Table of Contents
  • Latest reports

Description

Diet Aids are among the most rapidly growing categories of over-the-counter (OTC) products. Between 1998 and 2003, growth was driven by two main factors: changes in laws and lawsuits relating to the industry, and changes in consumer attitudes toward weight loss. Because both of these factors are subject to rapid and unpredictable shifts, the diet aids category remains a highly volatile market.

The consumer attitude towards OTC diet aids has shown extreme changes during the last couple of years. While a PPA or an Ephedra controversy has put the consumers on the back foot, the increase in the number of overweight people and consumer attitude towards weight reduction has made sure that this market continues to grow. The burgeoning number of overweight people in the US is a clear indicator of the possible growth in the diet aids segment despite regulatory action against one or another product type.

This report presents an in-depth analysis of the performance of OTC diet-aid products in the US market. The analysis while capturing the highlights of market players and leading brands’ performance in terms of revenue growth and volume growth also identifies key issues and trends affecting the marketplace. The analysis includes projections for the year 2003 to 2005, based on data available as of September 29, 2003.

Data on the demographics and preferences of consumers as well as various competitors’ ad spends are included. Profiles of the top 25 marketers and 45 products round out the market picture.

Table of Contents

Chapter One: Executive Summary

  • Market Overview
  • Market Players
  • Top Brands
  • Key Issues
  • Outlook
  • Definitions, Scope, and Methodology
  • Definitions
  • Scope of Analysis
  • Methodology

Chapter Two: The Market

  • Market Overview
  • The Reaction
  • What the Companies Did
  • History Repeats Itself
  • New Opportunities
  • Effect on Retailers
  • Market Size and Growth
  • Market Projections
  • Key Growth Drivers

Chapter Three: The Marketers

  • Overview
  • Performance analysis
  • Market Players
  • Top Brands
  • Average Revenue per Unit Comparison

Chapter Four: Advertising & Promotion

  • Advertising Guidelines & Regulations
  • Ephedra-Related Litigations

Chapter Five: The Consumer

  • Diet Control
  • Diet Control (by Age)
  • Diet Control (by Gender)
  • Diet Control (by Education Level)
  • Diet Control (by Household Income)
  • Market for Pills and Candies (Non-prescription diet-aid products)
  • Market for Pills and Candies (by Age)
  • Market for Pills and Candies (by Gender)
  • Market for Pills and Candies (by Level of Education)
  • Pills and Candies Market (by Household Income)
  • Overweight and Related Ailments
  • Overweight-Related Ailments in the Past 12 Months (by Age)
  • Overweight-Related Ailments in the Past 12 Months (by Gender)
  • Overweight-Related Ailments in the Past 12 Months (by Education Level)
  • Overweight-Related Ailments in the Past 12 Months (by Household Income)
  • Other Health-Related Behavior
  • Professionals Consulted in the Last 12 months
  • Consumption of Drugs in the last 12 months
  • Negative Attitude towards OTC- Non-prescription Products

Chapter Six: Company Profiles

  • Alva-Amco Pharm Co Inc.
  • Overview
  • Core Business
  • Product Category/Description
  • Apothecus Pharmaceutical Corp
  • Applied Nutrition Corp.
  • Atkins Nutritionals, Inc.
  • CCA Industries, Inc
  • Chattem, Inc.
  • Dutch International Products, Inc
  • Enforma Natural Products, Inc.
  • Health Nutrition Systems International
  • Leiner Health Products LLC
  • Mason Distributors, Inc.
  • Metabolife International Inc
  • MuscleTech Research and Development, Inc.
  • Natrol Inc
  • Nature’s Bounty
  • NVE Pharmaceuticals
  • Omni Nutraceuticals Inc
  • Patent Health LLC
  • Richardson Labs
  • Sundown Vitamins Inc
  • Telebrands Corporation
  • Thin and Slim Naturally (TSN Labs)
  • Twin Labs Inc
  • Weider Nutrition Group Inc
  • Windmill Consumer Products

Chapter Seven: Product Profiles

  • Acutrim Natural AM
  • Atkins Diet
  • Block and Bind
  • Carb Cutter
  • Chitosol™
  • Chroma Slim
  • Cidermax™
  • Dexatrim
  • Dexatrim Natural™
  • Dexatrim Results®
  • DIET SYSTEM 6®
  • Enforma Acceloron ™
  • Enforma Fattrapper
  • Fat Cutter Plus
  • Hydroxycut
  • Mega G
  • Mega T Green Tea
  • Metabolife 356®
  • Absorbitol Fat Binder
  • Metabolife Supplement – Ephedra free
  • Metab-O-Lite
  • Metab-O-Lite Plus
  • Metab-o-Loss
  • Metab-o-value
  • Natural Balance Fat Magnet
  • Metab-o-surge
  • The New Grapefruit Diet
  • Patent Lean Supplement
  • Schiff
  • Stacker 2
  • Stacker 2 Lite
  • Stacker 3
  • Sundown
  • T Lite
  • TwinLab Diet Fuel
  • TwinLab Energy Fuel
  • TwinLab Ever Slender
  • TwinLab Metabolift
  • TwinLab Ripped Fuel
  • Ultra Chroma Slim
  • Ultra diet pep
  • Weider Fat Burner
  • Xenadrine EFX Dietary
  • Xenadrine RFA 1
  • Xetalean

Appendix: Regulatory and Industry Contacts

List of Exhibits

Chapter Two: The Market

  • Figure 1: OTC Diet Aid Candy/Tablet Market, 2002-2003
  • Figure 2: Quarter-Wise Sales of OTC Diet Aid Candy/Tablets through FDM 2002-2003
  • Figure 3: US OTC Diet Aid Candy/Tablet Market Unit Sales and Dollar Volume 2001-2003

Chapter Three: The Marketers

  • Table 1: Top OTC Diet Aid Candy/Tablet Sellers by Market Share, 2003
  • Figure 4: Top 10 Market Players’ Quarterly Performance, 2003
  • Table 2: Top ten OTC Diet Aid Candy/Tablet Sellers for 52-Week Period Ending October 5, 2003
  • Figure 5: Quarterly Analysis of Top Companies, 2002 vs 2003
  • Figure 6: Top ten OTC Diet Aid Candy/Tablet Sellers 2000-2002
  • Table 3: Market Shares of Top OTC Diet Aid Candy/Tablet Products 2002-2003
  • Figure 7: Quarterly Performance of Top OTC Diet Aid Candy/Tablet Products 2003
  • Table 4: Top OTC Diet Aid Candy/Tablet Brands for 52-week Period Ending October 5, 2003
  • Figure 8: Quarterly Performance of Top Brands 2002 vs 2003
  • Figure 9: Top ten candy/tablet brands, 2000-2002
  • Table 5: Average Revenue per Unit (ARPU) for Top Brands 2002
  • Table 6: ARPU in 2002 for the Top Diet Aids Companies

Chapter Four: Advertising & Promotion

  • Table 7: Ad Spends by Candy/Tablet Brands, 2002
  • Table 8: Ad Spend as a Percentage of Revenues for Top Brands 2002

Chapter Five: The Consumer

  • Figure 10: Profile of Non-Prescription Diet-Aid Users
  • Figure 11: Profiles of Diet-Aid Consumers by Age
  • Figure 12: Profile of Diet-Aid Consumers by Gender
  • Figure 13: Profile of Diet-Aid Consumers by Education Levels
  • Figure 14: Profile of Diet-Aid Consumers by Household Income
  • Figure 15: Profile of OTC Diet-Pills Users by Age
  • Figure 16: Profile of OTC Diet-Candies Users by Age
  • Figure 17: Self Diet – NonPrescription Product – Candies
  • Figure 18: Self Diet – Nonprescription Product – Pills
  • Figure 19: Diet-Aid Pills Users by Education Level
  • Figure 20: Diet-Aid Candy Users by Education Level
  • Figure 21: Diet-Aid Pills Users by Household Income
  • Figure 22: Diet-Aid Candies Users by Household Income
  • Figure 23: Profile of People with Overweight-Related Ailments in the Past 12 Months by Age
  • Table 9: Profile of OTC Drugs Users by Age
  • Figure 24: Profile of People with Overweight-Related Ailments in the Past 12 Months by Gender
  • Figure 25: Profile of People with Overweight-Related Ailments in the Past 12 Months by Education Level
  • Table 10: Profile of OTC Drugs Users by Education Level
  • Table 11: Profile of OTC Drugs Users by Household Income
  • Figure 26: People with Overweight-Related Ailments in the Past 12 Months by Household Income
  • Figure 27: Proffesionals Consulted in the Past 12 Months
  • Table 12: Percentage of People Gathering Health Information from Various Sources

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Outsourcing in Drug Discovery

    $2,062.00 – $4,152.00
  • Placeholder image

    The Market for Lead Optimization Tools and Services: Applying the New “Omics” to Enhance Drug Discovery

    $1,875.00 – $3,750.00
  • Placeholder image

    Market for Rx-to-OTC Switches, 3rd Edition, The

    $2,625.00 – $5,250.00
  • Placeholder image

    Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003

    $795.00 – $1,590.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Emerging Cancer Vaccine Market, TheThe Worldwide Market For Dialysis Equipment, Supplies, and Services
Scroll to top